Impact factor jama oncol
Witryna5 lip 2024 · Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. ... JAMA Oncol. 2024;5(10):e191870. doi: ... Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American Society of Clinical Oncology Survey. WitrynaJAMA Oncol. 2024 Aug 15;5(11):1605-1613. doi: 10.1001/jamaoncol.2024.2109. Online ahead of print. ... Importance: To our knowledge, no randomized clinical trials have assessed the effects of the combination of weight loss and home-based exercise programs on lymphedema outcomes.
Impact factor jama oncol
Did you know?
Witryna24 mar 2024 · Impact factor 3.467 (2024) Five year impact factor 23 days Submission to first decision (Median) 335,089 (2024) Downloads. Latest issue. Volume 28. Issue 4, April 2024 View all volumes and issues. Latest articles. The clinical impacts of postoperative complications after colon cancer surgery for the clinical course of …
WitrynaThe Journal Impact Factor is defined as all citations to the journal in the current JCR year to items published in the previous two years, divided by the total number of … WitrynaThe journal’s impact factor of 31.8 placed us as one of the highest-ranking oncology journals. Choosing the best articles for the journal was rewarding but challenging. We …
Witryna2374-2437 (print) 2374-2445 (web) Links. Journal homepage. Online access. Online archive. JAMA Oncology is a monthly peer-reviewed medical journal published by the American Medical Association. It covers all aspects of medical oncology, radiation oncology, and surgical oncology, as well as subspecialties. The journal was … WitrynaJAMA Oncology is committed to publishing influential original research, opinions, and reviews that advance the science of oncology and improve the clinical care of …
Witryna27 maj 2024 · JAMA Oncology Impact Score 2024-2024 The impact score (IS) 2024 of JAMA Oncology is 9.35, which is computed in 2024 as per its definition. JAMA …
Witryna12 kwi 2024 · Lymph node status is an important long-term prognostic factor for patients with iCCA. 32 Specifically, the presence of lymph node metastases not only adversely affects OS but also influences the relative effect of tumor number and vascular invasion on survival. 33 Therefore, assessment of the nodal basin should be performed at … bird of prey outlineWitrynaJAMA Oncology is committed to publishing influential original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer. ... three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric. Cites per ... bird of prey offer feathers to the hawkWitryna23 sty 2008 · Context Comorbidities may increase the negative effects of specific anticancer treatments such as androgen suppression therapy (AST).. Objectives To compare 6 months of AST and radiation therapy (RT) to RT alone and to assess the interaction between level of comorbidity and all-cause mortality.. Design, Setting, and … damn daniel back it again with the white vansWitrynaEffect of Home-Based Exercise and Weight Loss Programs on Breast Cancer-Related Lymphedema Outcomes Among Overweight Breast Cancer Survivors: The WISER … bird of prey persecutionWitrynaNowotwory J Oncol znajdują się także — toutes proportions gardées — wśród instytucjonalnych, a ich redaktor — wśród indywidualnych sygnatariuszy Deklaracji. ... The history and meaning of the journal impact factor. JAMA 2006; 295: 90–93. Grant B. New impact factors yield surprises. damn boi he thick roblox idWitryna14 kwi 2024 · 《Journal of Thoracic Oncology》发布于爱科学网，并永久归类相关SCI期刊导航类别中，本站只是硬性分析 "《J THORAC ONCOL》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技进步及社会发展带来积极促进作用。 bird of prey photography experienceWitryna1 mar 2024 · JAMA Oncol. 2024 Mar 1;7(3):386 ... Although treatment with first-generation epidermal growth factor receptor (EGFR) ... (80 mg, every day) plus intravenous bevacizumab (15 mg/kg, every 3 weeks) until progression or unacceptable toxic effects. The control arm received osimertinib monotherapy. damn cat single ergonomic feeding bowls